An investment firm has launched its first marijuana exchange-traded fund (ETF) in Europe.

The Medical Cannabis & Wellness UCITS ETF (XETRA:CBDX) began its listing on Tuesday (January 14), and is available to investors on the Deutsche Boerse XETRA exchange based in Germany.


The new ETF has 13 holdings at this time and is overseen by a partnership between Purpose Investments and European firm HANetf, which has the backing of investor Steve Cohen’s Point72 Ventures, according to a press release.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Nawan Butt, associate portfolio manager with Purpose Investments, told the Investing News Network (INN) the European investor market has been underserved when it comes to the cannabis growth story.

“At the forefront of European cannabis investing are family offices and hedge funds, which essentially have historically been named specific investors, and what we aim to offer them is a beta exposure to the industry as a whole,” said Butt.

“Our goal is to take the wins and take the experiences from these investors and introduce European retail investors to the cannabis investment space within their regulatory frameworks.”

The Purpose Investments representative said the firm has been working with HANetf for the past year to get this ETF off the ground.

“Most European investors are limited to how they can invest in cannabis,” Butt told INN, adding that the market itself is at a very early stage, a few years behind what’s currently seen in Canada and the US.

The appetite is there for growth, but the industry will have to overcome regulatory hurdles, such as the ability to invest in recreational cannabis. Once that opens up, the European investor will have more global access.

When asked about the process for adding new stocks to the fund’s holdings, Butt said the index will employ a quarterly rebalance.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“Which means on a quarterly basis, there will be moves,” Butt said. “This is not dissimilar to what we’ve seen with the (Horizons Marijuana Life Sciences Index ETF [TSX:HMMJ]), where they’ve had large moves and index participants on a quarterly basis.”

The fund made an active decision to not include any names with ties to the recreational cannabis industry, so this discounted a lot of the Canadian corporations with significant valuations.

Butt said the fund will target the medical industry, the cannabidiol wellness segment and ancillary options. Here’s a list of the initial holdings made available through the fund:

  • Corbus Pharmaceuticals Holdings (NASDAQ:CRBP)
  • Scotts Miracle-Gro (NYSE:SMG)
  • Innovative Industrial Properties (NYSE:IIPR)
  • GW Pharmaceuticals (NASDAQ:GWPH)
  • 22nd Century Group (NYSEAMERICAN:XXII)
  • Amyris (NASDAQ:AMRS)
  • Charlotte’s Web (TSX:CWEB,OTCQX:CWBHF)
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE)
  • Pharmacielo (TSXV:PCLO,OTCQX:PCLOF)
  • Cara Therapeutics (NASDAQ:CARA)

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

Positive distributor feedback and strong consumer interest accelerating launch with distributors

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that its wholly-owned subsidiary Naturo Group has successfully completed its initial shipment of TRACE plant-based products to one of Japan’s largest beverage distributors.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced an additional refreshment of its board of directors to further strengthen its leadership in the cannabis industry.

Keep reading... Show less

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it will host a scheduled conference call to discuss the results for its first quarter ended March 31, 2021 on Wednesday, May 19 th 2021 at 8:30 a.m. Eastern Time . The Company will report its financial results for the  quarter in advance of the call.

CONFERENCE CALL DETAILS

Keep reading... Show less